Carlos E Cardenas1, Sanne E Blinde2, Abdallah S R Mohamed3, Sweet Ping Ng4, Cornelis Raaijmakers5, Marielle Philippens5, Alexis Kotte5, Abrahim A Al-Mamgani6, Irene Karam7, David J Thomson8, Jared Robbins9, Kate Newbold10, Clifton D Fuller3, Chris Terhaard5. 1. Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: cecardenas@uabmc.edu. 2. Department of Radiation Oncology, Klinikum Kassel, Kassel, Germany. 3. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. 4. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Melbourne, Australia. 5. Department of Radiation Therapy, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. 6. Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 7. Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. 8. Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. 9. Department of Radiation Oncology, University of Arizona, Tucson, Arizona. 10. Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
Abstract
PURPOSE: Tumor and target volume manual delineation remains a challenging task in head and neck cancer radiation therapy. The purpose of this study was to conduct a multi-institutional evaluation of manual delineations of gross tumor volume (GTV), high-risk clinical target volume (CTV), parotids, and submandibular glands on treatment simulation magnetic resonance scans of patients with oropharyngeal cancer. METHODS AND MATERIALS: We retrospectively collected pretreatment T1-weighted, T1-weighted with gadolinium contrast, and T2-weighted magnetic resonance imaging scans for 4 patients with oropharyngeal cancer under an institution review board-approved protocol. We provided the scans to 26 radiation oncologists from 7 international cancer centers that participated in this delineation study. We also provide the patients' clinical history and physical examination findings, along with a medical photographic image and radiologic results. We used both the Simultaneous Truth and Performance Level Estimation algorithm and pair-wise comparisons of the contours, using overlap/distance metrics. Lastly, to assess experience and CTV delineation institutional practices, we had participants complete a brief questionnaire. RESULTS: Large variability was measured between observers' delineations for GTVs and CTVs. The mean Dice similarity coefficient values across all physicians' delineations for GTVp, GTVn, CTVp, and CTVn were 0.77, 0.67, 0.77, and 0.69, respectively, for Simultaneous Truth and Performance Level Estimation algorithm comparison, and 0.67, 0.60, 0.67, and 0.58, respectively, for pair-wise analysis. Normal tissue contours were defined more consistently when considering overlap/distance metrics. The median radiation oncology clinical experience was 7 years. The median experience delineating on magnetic resonance imaging was 3.5 years. The GTV-to-CTV margin used was 10 mm for 6 of 7 participant institutions. One institution used 8 mm, and 3 participants (from 3 different institutions) used a margin of 5 mm. CONCLUSIONS: The data from this study suggests that appropriate guidelines, contouring quality assurance sessions, and training are still needed for the adoption of magnetic resonance-based treatment planning for head and neck cancers. Such efforts should play a critical role in reducing delineation variation and ensure standardization of target design across clinical practices.
PURPOSE: Tumor and target volume manual delineation remains a challenging task in head and neck cancer radiation therapy. The purpose of this study was to conduct a multi-institutional evaluation of manual delineations of gross tumor volume (GTV), high-risk clinical target volume (CTV), parotids, and submandibular glands on treatment simulation magnetic resonance scans of patients with oropharyngeal cancer. METHODS AND MATERIALS: We retrospectively collected pretreatment T1-weighted, T1-weighted with gadolinium contrast, and T2-weighted magnetic resonance imaging scans for 4 patients with oropharyngeal cancer under an institution review board-approved protocol. We provided the scans to 26 radiation oncologists from 7 international cancer centers that participated in this delineation study. We also provide the patients' clinical history and physical examination findings, along with a medical photographic image and radiologic results. We used both the Simultaneous Truth and Performance Level Estimation algorithm and pair-wise comparisons of the contours, using overlap/distance metrics. Lastly, to assess experience and CTV delineation institutional practices, we had participants complete a brief questionnaire. RESULTS: Large variability was measured between observers' delineations for GTVs and CTVs. The mean Dice similarity coefficient values across all physicians' delineations for GTVp, GTVn, CTVp, and CTVn were 0.77, 0.67, 0.77, and 0.69, respectively, for Simultaneous Truth and Performance Level Estimation algorithm comparison, and 0.67, 0.60, 0.67, and 0.58, respectively, for pair-wise analysis. Normal tissue contours were defined more consistently when considering overlap/distance metrics. The median radiation oncology clinical experience was 7 years. The median experience delineating on magnetic resonance imaging was 3.5 years. The GTV-to-CTV margin used was 10 mm for 6 of 7 participant institutions. One institution used 8 mm, and 3 participants (from 3 different institutions) used a margin of 5 mm. CONCLUSIONS: The data from this study suggests that appropriate guidelines, contouring quality assurance sessions, and training are still needed for the adoption of magnetic resonance-based treatment planning for head and neck cancers. Such efforts should play a critical role in reducing delineation variation and ensure standardization of target design across clinical practices.
Authors: Anuradha Thiagarajan; Nicola Caria; Heiko Schöder; N Gopalakrishna Iyer; Suzanne Wolden; Richard J Wong; Eric Sherman; Matthew G Fury; Nancy Lee Journal: Int J Radiat Oncol Biol Phys Date: 2011-10-27 Impact factor: 7.038
Authors: Jan Unkelbach; Thomas Bortfeld; Carlos E Cardenas; Vincent Gregoire; Wille Hager; Ben Heijmen; Robert Jeraj; Stine S Korreman; Roman Ludwig; Bertrand Pouymayou; Nadya Shusharina; Jonas Söderberg; Iuliana Toma-Dasu; Esther G C Troost; Eliana Vasquez Osorio Journal: Radiother Oncol Date: 2020-10-08 Impact factor: 6.280
Authors: Jinzhong Yang; Benjamin Haas; Raymond Fang; Beth M Beadle; Adam S Garden; Zhongxing Liao; Lifei Zhang; Peter Balter; Laurence Court Journal: Phys Med Biol Date: 2017-11-14 Impact factor: 3.609
Authors: Carlos E Cardenas; Rachel E McCarroll; Laurence E Court; Baher A Elgohari; Hesham Elhalawani; Clifton D Fuller; Mona J Kamal; Mohamed A M Meheissen; Abdallah S R Mohamed; Arvind Rao; Bowman Williams; Andrew Wong; Jinzhong Yang; Michalis Aristophanous Journal: Int J Radiat Oncol Biol Phys Date: 2018-02-07 Impact factor: 7.038
Authors: Beth M Beadle; Kai-Ping Liao; Linda S Elting; Thomas A Buchholz; K Kian Ang; Adam S Garden; B Ashleigh Guadagnolo Journal: Cancer Date: 2014-01-13 Impact factor: 6.860
Authors: Anne W Lee; Wai Tong Ng; Jian Ji Pan; Sharon S Poh; Yong Chan Ahn; Hussain AlHussain; June Corry; Cai Grau; Vincent Grégoire; Kevin J Harrington; Chao Su Hu; Dora L Kwong; Johannes A Langendijk; Quynh Thu Le; Nancy Y Lee; Jin Ching Lin; Tai Xiang Lu; William M Mendenhall; Brian O'Sullivan; Enis Ozyar; Lester J Peters; David I Rosenthal; Yoke Lim Soong; Yungan Tao; Sue S Yom; Joseph T Wee Journal: Radiother Oncol Date: 2017-11-15 Impact factor: 6.280
Authors: Sweet Ping Ng; Brandon A Dyer; Jayashree Kalpathy-Cramer; Abdallah Sherif Radwan Mohamed; Musaddiq J Awan; G Brandon Gunn; Jack Phan; Mark Zafereo; J Matthew Debnam; Carol M Lewis; Rivka R Colen; Michael E Kupferman; Nandita Guha-Thakurta; Guadalupe Canahuate; G Elisabeta Marai; David Vock; Bronwyn Hamilton; John Holland; Carlos E Cardenas; Stephen Lai; David Rosenthal; Clifton David Fuller Journal: Clin Transl Radiat Oncol Date: 2018-08-02
Authors: Mischa de Ridder; Cornelis P J Raaijmakers; Frank A Pameijer; Remco de Bree; Floris C J Reinders; Patricia A H Doornaert; Chris H J Terhaard; Marielle E P Philippens Journal: Cancers (Basel) Date: 2022-06-20 Impact factor: 6.575
Authors: Ruta Zukauskaite; Christopher N Rumley; Christian R Hansen; Michael G Jameson; Yuvnik Trada; Jørgen Johansen; Niels Gyldenkerne; Jesper G Eriksen; Farhannah Aly; Rasmus L Christensen; Mark Lee; Carsten Brink; Lois Holloway Journal: Clin Transl Radiat Oncol Date: 2022-08-06